Nasdaq · Healthcare
Aeries Technology, Inc. (AERT)
As-reported financials and recent SEC filings for Aeries Technology, Inc., latest fiscal period FY2026. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$70.0M
Net income
$2.8M
Net margin
4.0%
Diluted EPS
$0.05
ROE
-93.3%
P/E (TTM)
—
Market cap
—
Debt / equity
-0.3×
Income statement (as reported)
| Line | FY2026 | FY2025 | FY2024 | FY2024 | FY2022 |
|---|---|---|---|---|---|
| Revenue | $70.0M | $70.2M | $72.5M | $53.1M | — |
| Gross profit | $17.3M | $16.7M | $21.6M | $13.7M | — |
| Operating income | $4.5M | $-28.8M | $3.0M | $2.3M | $-4.5M |
| Net income | $2.8M | $-21.6M | $17.3M | $1.7M | $9.8M |
| Diluted EPS | $0.05 | $-0.46 | $0.30 | — | — |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
SCHEDULE 13D/A2026-07-01
View on EDGAR →42026-06-30
View on EDGAR →8-K2026-06-12
View on EDGAR →8-K2026-06-10
View on EDGAR →S-82026-06-08
View on EDGAR →8-K2026-06-08
View on EDGAR →10-K2026-06-08
View on EDGAR →424B32026-04-03
View on EDGAR →Largest Healthcare peers
Go deeper on AERT
Search Aeries Technology, Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeOr check your whole portfolio free — no account needed.
Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.